Previous 10 | Next 10 |
Please click here to access all 3Q 2023 Trading Update related documents The Hague, November 16, 2023 - Continued commercial momentum in US business and increased capital generation Operating capital generation before holding funding and operating expenses increases by 16% compare...
The Hague, November 9, 2023 - Aegon will propose to its 2024 Annual General Meeting to appoint Albert Benchimol as a non-executive member of the Board of Directors for a four-year term. Mr. Benchimol (American/Canadian/Moroccan, 1957) brings more than 40 years of experience as a senior leader...
The Hague, September 30, 2023 - Aegon’s Extraordinary General Meeting of shareholders (EGM) today approved the cross-border conversion into a Bermuda Limited company. After the completion of the EGM, the change of Aegon’s legal seat to Bermuda has been effectuated, as a re...
The Hague, September 29, 2023 - Aegon’s Extraordinary General Meeting of shareholders (EGM) today approved the first step in the company’s redomiciliation to Bermuda and adopted all other agenda items. These included amendments to the Articles of Association of Aegon N.V. to reflect...
The Hague, August 17, 2023 - Today, Aegon N.V. has published the Agenda and Shareholder Circular for its two upcoming Extraordinary General Meetings of Shareholders (EGM) on September 29 and September 30, 2023. As announced on June 30, 2023, the Bermuda Monetary Authority (BMA) informed Aegon...
Please click here to access all 1H2023 results related documents The Hague, August 17, 2023 - Starting the next chapter of Aegon’s transformation with solid 1H 2023 performance IFRS results from now on reported under the new insurance accounting standard IFRS 17 N...
The Hague, July 17, 2023 - Aegon today announces that a coupon rate of 3.93894% has been determined for the USD Perpetual Capital Securities (ISIN: NL0000116168) (the Securities). The coupon rate, which was determined in accordance with the provisions described in conditions 5(c) and 5(e) of ...
The Hague, July 6, 2023 - Aegon today announces the beginning of a EUR 1.5 billion share buyback program. This follows the completion of the combination of its Dutch pension, life and non-life insurance, banking, and mortgage origination activities with a.s.r. that was announced on July 4, 20...
The Hague, July 4, 2023 - La Banque Postale and Aegon Asset Management (Aegon AM) are pleased to announce the extension of their asset management joint venture partnership in LBP AM through 2035. Aegon AM originally entered into the joint venture with La Banque Postale in 2015 and holds a 25% sta...
The Hague, July 4, 2023 - Aegon today announces the completion of the combination of its Dutch pension, life and non-life insurance, banking, and mortgage origination activities with a.s.r., and the beginning of its asset management partnership with a.s.r. As part of the transaction, Aegon receiv...
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET About to begin a phase 2b/3 multinational study of Ifenprodil Algernon Pharmaceuticals is a drug repurposing company. They're a phase 2 clinical stage company advancing a drug called Ifenprodil for idiopathic pulmonary fibrosis, but also as a potential thera...
2024-03-27 17:08:02 ET A stroke can be a devastating and debilitating event for an individual and their family, and a major burden on the health care system. Over 15 million people suffer strokes every year, and 85% of those have some form of disability as a result. Stroke-related cos...
2024-03-27 17:08:02 ET Stocks to Invest in: Healthcare Focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease Algernon is a drug re-purposing company that investigates safe, already approved drugs, inclu...